No Data
No Data
Earnings Not Telling The Story For Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) After Shares Rise 26%
Is Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Recent Stock Performance Influenced By Its Financials In Any Way?
Shandong Lukang Pharmaceutical (600789.SH): Piperacillin has obtained the approval of the application for listing of chemical raw materials.
Shandong Lukang Pharmaceutical (600789.SH) announced that it has recently received the announcement issued by the National Medical Products Administration regarding...
Shandong Lukang Pharmaceutical's semi-annual performance forecast for 2024 is expected to increase.
Shandong Lukang Pharmaceutical (600789.SH): It is expected that the net income for the first half of the year will increase by 122%-137% year on year.
On July 12th, Gelunhui announced that Shandong Lukang Pharmaceutical (600789.SH) preliminarily estimated that its net income attributable to the owners of the parent company in the first half of 2024 will be between 0.29 billion yuan and 0.31 billion yuan, a year-on-year increase of 122% to 137%. The estimated net income after deducting non-recurring gains and losses, which will be attributable to the owners of the parent company in the first half of 2024, will be between 88.16 million yuan and 99.66 million yuan, an increase of 9.5 million yuan to 21 million yuan compared to the same period last year, a year-on-year increase of 12% to 27%. (I) Impact of main business. In 2024, the company will continue to promote outstanding performance.
Shandong Lukang Pharmaceutical (600789.SH) received a government subsidy of 76.4477 million yuan.
Shandong Lukang Pharmaceutical (600789.SH) announced on June 21st that the company and its subsidiaries have received a total of 76.447 million yuan in various government special subsidies from January 1, 2024, to the date of this announcement. Among them, government subsidies related to income are 36.547 million yuan, accounting for 14.85% of the company's most recent audited net income; government subsidies related to assets are 39.9 million yuan, accounting for 1.10% of the company's most recent audited net assets.
No Data